J
Jane M. Andrews
Researcher at Royal Adelaide Hospital
Publications - 329
Citations - 14638
Jane M. Andrews is an academic researcher from Royal Adelaide Hospital. The author has contributed to research in topics: Inflammatory bowel disease & Medicine. The author has an hindex of 48, co-authored 298 publications receiving 12270 citations. Previous affiliations of Jane M. Andrews include St. Vincent's Health System & Health Science University.
Papers
More filters
Journal ArticleDOI
Authors' reply: The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin and Quality of Life.
Journal ArticleDOI
Novel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD care
TL;DR: In Australia, annual hospitalization costs for IBD exceed 100 million Australian dollars (AUD) with overall estimated economic costs in Australia exceeding 2.7 billion AUD, according to the Australian Bureau of Statistics as discussed by the authors .
Journal ArticleDOI
S810 Efficacy Outcomes by Symptom-Based Response Status After Induction: Week-48 Results from the GALAXI 1 Trial of Guselkumab in Crohn’s Disease
Julián Panés,David T. Rubin,Bruce E. Sands,Walter Reinisch,Geert R. D'Haens,Aparna Sahoo,Mary Ellen Frustaci,Zijiang Yang,William J. Sandborn,Remo Panaccione,Tadakazu Hisamatsu,Silvio Danese,Jane M. Andrews,Brian G. Feagan,Mario Arbeláez Gómez,Natalie A. Terry +15 more
TL;DR: The GALAXI 1 study as mentioned in this paper evaluated the efficacy and safety of guselkumab (GUS) in patients with moderate to severe Crohn's disease (CD).
Posted ContentDOI
An extremes of phenotype approach confirms significant genetic heterogeneity in patients with ulcerative colitis.
Graham L. Radford-Smith,Sally Mortlock,Anton Lord,Grant W. Montgomery,Martha Zakrzewski,Lisa A. Simms,Krupa Krishnaprasad,Katherine Hanigan,James D. Doecke,Alissa Walsh,Ian C. Lawrance,Peter A. Bampton,Jane M. Andrews,Gillian Mahy,Susan J. Connor,Miles P. Sparrow,Sally Bell,Timothy H Florin,Jake Begun,Richard B. Gearry +19 more
TL;DR: In this paper, the authors identify genomic risk variants specific to mild and/or severe forms of UC, explore variations in the effect size of known risk variants and assess the clinical value of a genetic risk score (GRS).
BRIEF COMMUNICATION Do We Know What Patients Want? The Doctor-Patient Communication Gap in Functional Gastrointestinal Disorders
TL;DR: There is a communication gap between patients and gastroenterologists in FGIDs and this communication gap and lack of acceptance of a functional diagnosis are likely to influence future management and health care utilization.